Table 3. Multivariate logistic regression analysis for chemotherapy resistance.

	OR	95% CI	P-value
miRNA
miR-1234-3p	0.26	0.11–0.64	0.003
Histologic type
Serous adenocarcinoma	-	-	-
Mucinous adenocarcinoma	0.27	0.03–2.44	0.244
Endometrioid adenocarcinoma	1.34	0.22–8.16	0.754
Clear Cell adenocarcinoma	5.22	0.72–37.83	0.102
FIGO stage
I
II	55.70	0.00–1.8873	0.962
III	105.63	0.00–3.5473	0.956
IV	184.28	0.00–6.1873	0.951
Age per 10 years	1.08	0.73–1.60	0.707
Performance score1 low vs. high	0.88	0.49–1.55	0.648
BMI group
18.5–25	-	-	-
<18.5	968.93	0.00–6.47155	0.968
>25–30	0.09	0.00–7.9349	0.968
>30	0.18	0.00–1.6050	0.977
Residual tumor
Yes	-	-	-
No	0.45	0.25–0.80	0.0064

OR = odds ratio, CI = confidence interval, FIGO = International Federation of Gynecology and

Obstetrics.

¹WHO/Eastern Cooperative Oncology Group performance score.